Prestige Consumer Healthcare (PBH) EBIT Growth (1y) (2011 - 2025)
Prestige Consumer Healthcare (PBH) EBIT Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 25.63% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | -1.30% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -14.89% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 719.49% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | 117.78% |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 23.29% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -450.06% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | -20.32% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 273.62% |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.27 Bn | 157.37 Mn | -10.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.30% |
| Sep 30, 2025 | -5.54% |
| Jun 30, 2025 | -0.40% |
| Mar 31, 2025 | 7.64% |
| Dec 31, 2024 | 5.91% |
| Sep 30, 2024 | -4.43% |
| Jun 30, 2024 | -15.43% |
| Mar 31, 2024 | 129.24% |
| Dec 31, 2023 | -0.40% |
| Sep 30, 2023 | 4.58% |
| Jun 30, 2023 | -2.09% |
| Mar 31, 2023 | -462.93% |
| Dec 31, 2022 | 5.56% |
| Sep 30, 2022 | 7.42% |
| Jun 30, 2022 | -4.74% |
| Mar 31, 2022 | 9.15% |
| Dec 31, 2021 | 12.46% |
| Sep 30, 2021 | 7.76% |
| Jun 30, 2021 | 14.01% |
| Mar 31, 2021 | -4.03% |